Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02594917 · ClinicalTrials.gov registry record

Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
13
Enrollment target

NCT02594917 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02594917 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
13 participants
Enrollment target

Study Summary

The investigators are performing this research study to determine whether having low iron-sulfur cluster levels can cause a disease known as pulmonary hypertension (PH). PH is defined as abnormally high blood pressure in the arteries of the lungs. Usually, small specialized structures inside each human cell called mitochondria are in charge of generating energy within lung arteries for normal function. During situations of disease or stress, lung arteries undergo a change in the function of mitochondria, resulting in the development of PH. In studies on mice, investigators have learned that alterations in the production of specific metal complexes called iron-sulfur clusters are responsible for these changes. This makes it more likely that mice will develop PH. In this study, the investigators want to find out if alteration of iron-sulfur cluster formation leads to increased likelihood of developing PH in humans.

Interventions

  • OTHER Blood draw
  • PROCEDURE Right Heart Catheterization

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2015-10
Est. Completion 2023-09-01

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02594917

The ClinicalTrials.gov registry entry for NCT02594917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.

NCT02594917 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02594917 about?

NCT02594917 is a clinical study titled "Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension". The investigators are performing this research study to determine whether having low iron-sulfur cluster levels can cause a disease known as pulmonary hypertension (PH). PH is defined as abnormally high blood pressure in the arteries of the lungs. Usually, small specialized structures inside each h...

What is the current status of trial NCT02594917?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2023-09-01.

What interventions are being tested in trial NCT02594917?

The interventions under investigation include: Blood draw (OTHER), Right Heart Catheterization (PROCEDURE).

Who is sponsoring clinical trial NCT02594917?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.